DSpace About DSpace Software 日本語

01 奈良県立医科大学 >
012 大学院 >
0122 学位請求論文 >
01221 博士論文(医学) >
2015年度 >

Please use this identifier to cite or link to this item: http://hdl.handle.net/10564/3072

Title: Clinical impact of herpesvirus entry mediator expression in human hepatocellular carcinoma.
Other Titles: ヒト肝細胞癌においてherpesvirus entry mediatorの発現がもたらす影響
Authors: Hokuto, Daisuke
Sho, Masayuki
Yamato, Ichiro
Yasuda, Satoshi
Obara, Shinsaku
Nomi, Takeo
Nakajima, Yoshiyuki
Keywords: HVEM
Tumour immunity
Issue Date: Jan-2015
Publisher: Elsevier
Citation: European journal of cancer Vol.51 No.2 p.157-165(2015.01)
Abstract: BACKGROUND: Herpes virus entry mediator (HVEM), also known as tumour necrosis factor receptor (TNFR) superfamily 14, regulates a variety of physiological and pathological responses in both innate and acquired immunity. Although HVEM is also suggested to be a critical regulator in tumours, actual roles in human cancer are largely unknown. This study aimed to clarify clinical importance of HVEM in human hepatocellular carcinoma (HCC). PATIENTS AND METHODS: We studied HVEM expression in 150 HCC patients to explore its clinical relevance, and we examined tumour infiltrating T cells and local immune status of them. RESULTS: HVEM was expressed in HCC cells, while no or only limited expression was observed in normal tissues in the liver. Tumour HVEM expression was significantly correlated with age, serum protein induced by vitamin K absence or antagonist-II (PIVKA-II) level, vascular invasion and tumour node metastasis (TNM) stage. Furthermore, tumour HVEM expression significantly correlated with postoperative recurrence and survival. Importantly, multivariate analysis indicated that the HVEM status had an independent prognostic value. Furthermore, HVEM status was inversely correlated with tumour-infiltrating CD4(+), CD8(+) and CD45RO(+) lymphocytes. In addition, it was also associated with reduced expression of perforin, granzyme B and interferon-γ (IFN-γ). Taken together, tumour-expressing HVEM plays a functionally important role in HCC. CONCLUSION: Tumour-expressing HVEM plays a critical role in human HCC, possibly through regulating immune evasion. Therefore, targeting HVEM may be a novel promising therapeutic strategy for HCC.
Description: 博士(医学)・乙第1359号・平成27年5月28日
Copyright © 2014 Elsevier Ltd.
URI: http://hdl.handle.net/10564/3072
ISSN: 09598049
Academic Degrees and number: 24601B1359
Degree-granting date: 2015-05-28
Degree name: 博士(医学)
Degree-granting institutions: 奈良県立医科大学
Appears in Collections:2015年度

Files in This Item:

File Description SizeFormat
01_乙1359本文の要旨.pdf乙1359本文の要旨264.96 kBAdobe PDFView/Open
02乙1359_審査要旨.pdf乙1359審査要旨691.85 kBAdobe PDFView/Open
03_乙1359本文.pdf乙1359本文1.53 MBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.


Valid XHTML 1.0! DSpace Software Copyright © 2002-2010  Duraspace - Feedback